^
BIOMARKER:

BRAF V600K

i
Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
BRAF V600K
Melanoma
trametinib + dabrafenib
Sensitive
:
A1
BRAF V600K
Melanoma
trametinib
Sensitive
:
A1
BRAF V600K
Melanoma
encorafenib + binimetinib
Sensitive
:
A1
BRAF V600K
Melanoma
vemurafenib + cobimetinib
Sensitive
:
A1
BRAF V600K
Cutaneous Melanoma
trametinib + dabrafenib
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
pembrolizumab
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
nivolumab
Sensitive
:
A2
BRAF V600K
Melanoma
dabrafenib
Sensitive
:
A2
BRAF V600K
Cutaneous Melanoma
encorafenib + binimetinib
Sensitive
:
A2
BRAF V600K
Melanoma
pembrolizumab
Sensitive
:
B
BRAF V600K
Melanoma
encorafenib
Sensitive
:
B
BRAF V600K
Melanoma
trametinib + dabrafenib + PDR001
Sensitive
:
B
BRAF V600K
Cutaneous Melanoma
trametinib
Sensitive
:
C1
BRAF V600K
Solid Tumor
encorafenib + binimetinib
Sensitive
:
C1
BRAF V600K
Melanoma
pembrolizumab + trametinib + dabrafenib
Sensitive
:
C2
BRAF V600K
Melanoma
atezolizumab + vemurafenib + cobimetinib
Sensitive
:
C2
BRAF V600K
Solid Tumor
trametinib + dabrafenib + AT13387
Sensitive
:
C2
BRAF V600K
Melanoma
vemurafenib
Sensitive
:
C2
BRAF V600K
Melanoma
BGB-283
Sensitive
:
C3
BRAF V600K
Melanoma
nivolumab
Sensitive
:
C3
BRAF V600K
Melanoma
9-ING-41
Sensitive
:
C3
BRAF V600K
Melanoma
PD1 inhibitor + CTLA4 inhibitor
Sensitive
:
C3
BRAF V600K
Melanoma
Immunotherapy
Sensitive
:
C3